Advanced Enzyme Technologies Ltd.

359.50 +29.85 ▲9.1%

06 December 2023, 04:09:35 PM
Volume: 4,571,262

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.advancedenzymes.com
Market Cap 4,025.67 Cr.
Enterprise Value(EV) 3,920.33 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 11.16 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 32.26 Trailing Twelve Months Ending 2023-09
Industry PE 38.60 Trailing Twelve Months Ending 2023-09
Book Value / Share 111.63 Trailing Twelve Months Ending 2023-09
Price to Book Value 3.22 Calculated using Price: 360.00
Dividend Yield 1.39 Period Ending 2023-03
No. of Shares Subscribed 11.18 Cr. 111,824,075 Shares
FaceValue 2
About Advanced Enzyme Technologies Ltd.
The company is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (R&D) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions. Its experienced and qualified R&D team strives to develop creative, cost-effective unique and innovative solutions, thereby enabling their customers to develop superior products and processes. The company products assist its customers in making most of their resources, optimizing their processes, improving their product quality, saving their time and money while also mitigating the impact on the environment. It supplies these value-added and eco-safe enzyme products to diverse end-user industries like human healthcare and nutrition, animal nutrition, food processing, baking, dairy and cheese processing, fruit and vegetable processing, cereal extraction, brewing, grain processing, protein processing, oil and fat processing, biomass processing, textile processing, leather processing, paper & pulp processing, bio-fuels, bio-catalysis etc. Although, the company has the capability to manufacture enzymes using all the four natural origins viz. plant, animal, bacterial and fungal, their major focus is on developing enzymes through microbial fermentation.

Advanced Enzyme Technologies Ltd. Delivery

Delivered Qty
Traded Qty

Advanced Enzyme Technologies Ltd. Performance

1 Day
+9.06%
1 Week
+8.10%
1 Month
+16.57%
3 Month
+11.25%
6 Month
+26.85%
1 Year
+17.04%
2 Year
+7.83%
5 Year
+101.63%
10 Year

Advanced Enzyme Technologies Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 27.31 31.32 25.06 18.34 18.82 17.61 16.77 12.04 8.94
Return on Capital Employed (%) 25.49 35.68 31.53 25.88 24.96 23.21 22.93 16.66 12.26
Return on Assets (%) 12.81 17.81 18.00 14.28 15.13 14.98 14.27 10.28 7.78

Advanced Enzyme Technologies Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 212 278 464 559 679 840 971 1,089 1,235 1,248
Non Curr. Liab. 64 56 32 47 35 44 49 59 49 46
Curr. Liab. 131 111 65 99 65 60 68 60 78 87
Minority Int. 4 5 21 23 26 28 62 52 49 50
Equity & Liab. 412 450 583 727 805 971 1,149 1,260 1,411 1,433
Non Curr. Assets 307 311 440 517 523 596 633 656 688 696
Curr. Assets 104 140 143 211 282 376 516 604 722 737
Misc. Exp. not W/O
Total Assets 412 450 583 727 805 971 1,149 1,260 1,411 1,433

Advanced Enzyme Technologies Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 223 294 329 391 420 444 502 529 541 586
Other Income 3 1 3 3 6 6 9 6 25 32
Total Income 226 295 332 394 425 450 511 536 566 618
Total Expenditure -133 -156 -178 -227 -237 -241 -269 -327 -383 -405
PBIDT 93 139 154 166 188 209 241 209 183 214
Interest -9 -8 -4 -9 -5 -4 -3 -3 -3 -3
Depreciation -9 -9 -13 -18 -21 -26 -29 -35 -35 -35
Taxation -23 -41 -44 -45 -46 -46 -59 -47 -37 -47
Exceptional Items -4 -4 -4
PAT 52 77 93 94 116 133 151 124 104 125
Minority Interest -1 -1 -1 -3 -5 -4 -5 -4 2 0
Share Associate
Other Related Items
Consolidated Net Profit 51 76 92 90 111 129 146 120 106 125
Adjusted EPS 5 7 8 8 10 12 13 11 9 11

Advanced Enzyme Technologies Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 56 54 93 107 116 129 141 163 122 140
Cash Fr. Inv. -9 -11 -5 -60 -78 -125 -45 -26 -4 -298
Cash Fr. Finan. -33 -36 -63 -65 -2 -43 -39 -26 -49 -26
Net Change 13 6 26 -18 36 -39 58 111 70 -184
Cash & Cash Eqvt 2 4 25 8 61 23 83 192 267 96

Advanced Enzyme Technologies Ltd. Shareholding Pattern

9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 52.55 52.71 52.70 52.70 49.87 49.87 49.87 46.52 45.92
Public 47.45 47.29 47.30 47.30 50.13 50.13 50.13 53.48 54.08
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Advanced Enzyme Technologies Ltd. Announcements

Tue, 28 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet - Partners Group
Fri, 24 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet
Thu, 23 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet

Advanced Enzyme Technologies Ltd. Technical Scans

Wed, 06 Dec 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week High Close Crossing Last Week High
Close Crossing Last Month High Close Crossing Last Month High

Advanced Enzyme Technologies Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,505.54 1,240.35 +0.1%
Divi's Laboratories Ltd. 99,132.60 3,734.45 -0.2%
Cipla Ltd. 97,689.40 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. 95,542.33 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. 79,632.26 5,543.10 -0.7%
Mankind Pharma Ltd. 78,289.00 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. 70,428.80 2,080.95 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.80 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 74.44 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-09 28.29 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.77 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.17 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 61.07 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.80 2,080.95 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.97 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 7.82 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-09 3.94 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.75 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.25 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.29 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.50 2,080.95 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,080.95 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,080.95 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,080.95 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,080.95 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,080.95 -0.9%

Advanced Enzyme Technologies Ltd. FAQ's

What is Advanced Enzyme share price?

Can I buy Advanced Enzyme shares now?

What is the Dividend Yield of Advanced Enzyme?

What is the Market Cap of Advanced Enzyme?

What are the key metrics to analyse Advanced Enzyme?

What is the 52 Week High and Low of Advanced Enzyme?

What is the trend of Advanced Enzyme share price?